You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCC, cirrhosis, chronic liver disease, hepatitis B

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis b, Liver Fibrosis Trial in Konya (Serum regucalcin level)

Completed
  • Chronic Hepatitis b
  • Liver Fibrosis
  • Serum regucalcin level
  • Konya, Turkey
    Konya Training and Research Hospital
Jun 23, 2022

Thrombocytopenia, Hepatitis B, Chronic, Acute-On-Chronic Liver Failure Trial in Guangzhou (Avatrombopag, Artificial Liver

Recruiting
  • Thrombocytopenia
  • +2 more
  • Guangzhou, Guangdong, China
    Third Affiliated Hospital of Sun Yat-sen University
Nov 8, 2022

Liver Disease Chronic, Fibrosis, Liver, Liver Steatoses Trial in London (Ultrasound based Elastography and fat quantification)

Recruiting
  • Liver Disease Chronic
  • +6 more
  • Ultrasound based Elastography and fat quantification
  • London, United Kingdom
    Nuran Seneviratne
Oct 26, 2023

Utilization of MAsS in Patients Undergoing LT for HCC

Recruiting
  • NAFLD
  • +5 more
    • New York, New York
      Columbia University Irving Medical Center
    Jun 29, 2022

    Liver Cirrhoses Trial in Jakarta (Allogeneic Umbilical Cord Mesenchymal Stem Cell)

    Recruiting
    • Liver Cirrhoses
    • Allogeneic Umbilical Cord Mesenchymal Stem Cell
    • Jakarta, DKI Jakarta, Indonesia
      Cipto Mangunkusumo hospital
    Jun 12, 2022

    Prevention of HCC Using Mobile Phone Applications

    Not yet recruiting
    • Liver Cirrhosis
    • Hepatitis B
    • Use of mobile health application
    • +3 more
    • (no location specified)
    Oct 25, 2021

    Hepatitis B, Chronic Trial in Shanghai, Beijing (Hydronidone, Placebo, Entecavir)

    Completed
    • Hepatitis B, Chronic
    • Shanghai, Shanghai, China
    • +1 more
    Jun 21, 2022

    Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body

    Recruiting
    • Liver Cirrhosis
    • +2 more
    • Handgrip strength test
    • +2 more
    • Roma, RM, Italy
      CEMAD
    Oct 20, 2023

    Hepatitis B, Chronic Trial in China (Tenofovir disoproxil fumarate)

    Completed
    Has Results
    • Hepatitis B, Chronic
    • Tenofovir disoproxil fumarate
    • Guangzhou, Guangdong, China
    • +18 more
    Nov 26, 2021

    Cirrhosis Due to Hepatitis B Trial in Wuhan (UC-MSCs, Saline solution)

    Recruiting
    • Cirrhosis Due to Hepatitis B
    • UC-MSCs
    • Saline solution
    • Wuhan, Hubei, China
      Renmin Hospital of Wuhan University
    Aug 18, 2022

    COVID-19 Vaccination and Prevalence of COVID-19 in Chronic Liver

    Not yet recruiting
    • Chronic or Recovered Hepatitis B
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      CHronic Hepatopathies Associated With ALcohol Consumption aNd

      Not yet recruiting
      • Non-Alcoholic Fatty Liver Disease
      • +4 more
      • Liver biopsy
      • (no location specified)
      Nov 12, 2022

      Hepatitis B, Chronic, Fibrosis, Liver, Diabetes, Type 2 Trial in Seoul (Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg)

      Active, not recruiting
      • Hepatitis B, Chronic
      • +2 more
      • Pioglitazone 15 Mg Oral Tablet
      • Evogliptin 5mg
      • Seoul, Korea, Republic of
      • +3 more
      Jul 21, 2022

      NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)

      Not yet recruiting
      • NAFLD Cirrhosis
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      May 5, 2023

      Liver Disease Chronic, Hepatitis B Virus Trial in Terrassa (Fendrix or HBVAXPRO 40)

      Completed
      • Liver Disease Chronic
      • Hepatitis B Virus
      • Fendrix or HBVAXPRO 40
      • Terrassa, Barcelona/Spain, Spain
        Hospital Universitari Mutua Terrassa
      Jul 7, 2022

      Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

      Available
      • Viral Hepatitis B
      • +6 more
      • REP 2139-Mg
      • +2 more
      • Vienna, Austria
      • +12 more
      Feb 1, 2023

      Patients With End Stage Liver Disease

      Not yet recruiting
      • Liver Cirrhosis
      • +6 more
        • Palo Alto, California
          Stanford Hospital
        Aug 23, 2023

        S100A8/A9 and Innate Immunity in Liver Disease

        Recruiting
        • Cirrhosis, Liver
        • +4 more
          • London Borough Of Wandsworth, London, United Kingdom
            Arjuna Singanayagam
          Mar 30, 2023

          Liver Cirrhosis Network Cohort Study

          Recruiting
          • Cirrhosis
          • +10 more
            • La Jolla, California
            • +13 more
            Feb 21, 2023

            Liver Cirrhosis, Acute on Chronic Liver Failure Trial in New Delhi (Relaxed Rotational Thromboelastometry, Standard Coagulation

            Not yet recruiting
            • Liver Cirrhosis
            • Acute on Chronic Liver Failure
            • Relaxed Rotational Thromboelastometry
            • Standard Coagulation Tests
            • New Delhi, Delhi, India
              Institute of Liver & Biliary Sciences
            Jan 6, 2023

            Cirrhosis, Cirrhosis, Liver, Cirrhosis Early Trial in United States (Rosuvastatin)

            Not yet recruiting
            • Cirrhosis
            • +10 more
            • La Jolla, California
            • +12 more
            Apr 14, 2023

            TruGraf Liver Gene Expression Serial Test

            Not yet recruiting
            • Autoimmune Liver Disease
            • +3 more
            • TruGraf®
            • (no location specified)
            Sep 27, 2023

            Combination of DPMAS and Low Volume PE for HBV Related ACLF

            Recruiting
            • Hepatitis B, Chronic
            • Acute-On-Chronic Liver Failure
            • Artificial liver support system
            • Guangzhou, Guangdong, China
              Third Affiliated Hospital of Sun Yat-sen University
            May 14, 2022

            Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)

            Recruiting
            • Liver Cirrhosis
            • +2 more
            • Prolonged-Release Pirfenidone
            • Guadalajara, Jalisco, Mexico
            • +1 more
            Sep 13, 2022

            Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty

            Recruiting
            • the Effect of NAFLD on CHB
              • Wuhan, Hubei, China
                Department and Institute of Infectious Disease
              Feb 24, 2022